Axitinib
Axitinib Brand Name– INLYTA What is Axitinib Axitinib is an oral agent that works by inhibiting receptor tyrosine kinases, including vascular endothelial growth factor receptors (VEGFR)-1, VEGFR-2, and VEGFR-3. It is approved for the treatment of advanced renal cell carcinoma (RCC) after failure of one prior systemic therapy. Progression-free survival was significantly improved with axitinib …
